BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21500349)

  • 1. A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens.
    Lee HJ; Na K; Kwon MS; Park T; Kim KS; Kim H; Paik YK
    Proteomics; 2011 May; 11(10):1976-84. PubMed ID: 21500349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen.
    Lee HJ; Na K; Kwon MS; Kim H; Kim KS; Paik YK
    Proteomics; 2009 Jun; 9(12):3395-408. PubMed ID: 19562805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery.
    Lee HJ; Kang MJ; Lee EY; Cho SY; Kim H; Paik YK
    Proteomics; 2008 Aug; 8(16):3371-81. PubMed ID: 18651672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens.
    Lee HJ; Na K; Choi EY; Kim KS; Kim H; Paik YK
    J Proteome Res; 2010 Jan; 9(1):308-18. PubMed ID: 19899825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.
    Na K; Lee EY; Lee HJ; Kim KY; Lee H; Jeong SK; Jeong AS; Cho SY; Kim SA; Song SY; Kim KS; Cho SW; Kim H; Paik YK
    Proteomics; 2009 Aug; 9(16):3989-99. PubMed ID: 19658107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients.
    Lee HJ; Cha HJ; Lim JS; Lee SH; Song SY; Kim H; Hancock WS; Yoo JS; Paik YK
    J Proteome Res; 2014 May; 13(5):2328-38. PubMed ID: 24628331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
    Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
    Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
    Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
    J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
    J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
    Lee YY; McKinney KQ; Ghosh S; Iannitti DA; Martinie JB; Caballes FR; Russo MW; Ahrens WA; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
    J Proteome Res; 2011 Nov; 10(11):5070-83. PubMed ID: 21913717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
    Feng JT; Liu YK; Song HY; Dai Z; Qin LX; Almofti MR; Fang CY; Lu HJ; Yang PY; Tang ZY
    Proteomics; 2005 Nov; 5(17):4581-8. PubMed ID: 16240287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. i-RUBY: a novel software for quantitative analysis of highly accurate shotgun-proteomics liquid chromatography/tandem mass spectrometry data obtained without stable-isotope labeling of proteins.
    Wada K; Ogiwara A; Nagasaka K; Tanaka N; Komatsu Y
    Rapid Commun Mass Spectrom; 2011 Apr; 25(7):960-8. PubMed ID: 21416533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.